Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros




Base de datos
Asunto de la revista
Intervalo de año de publicación
1.
Expert Rev Endocrinol Metab ; 19(3): 269-277, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38147023

RESUMEN

BACKGROUND: This study aimed to systematically review the effect of selenium and inositol combination on thyroid function, autoimmune characteristics in thyroid diseases. RESEARCH DESIGN AND METHODS: To identify eligible studies, a systematic search was conducted in the PubMed/MEDLINE, Science-Direct, CINHAL, EMBASE, SCOPUS, Psychinfo, Cochrane, ProQuest, and Web of Science were searched using the main concepts, and all English-written articles that were published between 2007 and 2022 and had an available full text were examined. RESULTS: The data analysis of this research revealed that after the simultaneous use of selenium and inositol supplements, the level of Triiodothyronine(T3) increased by 0.105 in patients with thyroid disorders although this increase was not significant (P-value: 0.228). The level of Thyroxine (T4) significantly increased by 0.06 (P-value: 0.04). Anti-Thyroid Peroxidase Antibody (TPOAb) titer decreased by 119.36%, which was not significant (P-value: 0.070). Finally, the level of Thyroid-stimulating hormone (TSH) decreased by 1.45%, which was a significant change (P-value: 0.001). CONCLUSION: It was observed that simultaneous use of selenium and inositol supplements did not change the T3 and TPOAb titer levels; however, it leads to a decrease in TSH and increase in T4 levels. Further studies are required due to the limited number of studies.


Asunto(s)
Suplementos Dietéticos , Inositol , Selenio , Enfermedades de la Tiroides , Glándula Tiroides , Humanos , Autoanticuerpos/sangre , Quimioterapia Combinada , Inositol/administración & dosificación , Inositol/farmacología , Inositol/uso terapéutico , Selenio/administración & dosificación , Selenio/farmacología , Enfermedades de la Tiroides/inmunología , Enfermedades de la Tiroides/tratamiento farmacológico , Glándula Tiroides/efectos de los fármacos , Tirotropina/sangre , Tiroxina/administración & dosificación , Tiroxina/sangre , Triyodotironina/sangre
2.
Diabetes Res Clin Pract ; 158: 107895, 2019 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-31669408

RESUMEN

With the increasing use of mobile phones, mHealth has grown to be a very promising subject. However, mHealth programs haven't been widespread in many countries, especially in developing countries. Health-related phone applications, and in particular diabetes-related mobile apps, are gaining more popularity by the day. Yet, there are still some concerns about the safety and effectiveness of these apps. In this short commentary, we will discuss the simple uses of mobile phones and how they can contribute to the communication between patients and health professional providers.


Asunto(s)
Uso del Teléfono Celular/tendencias , Teléfono Celular/instrumentación , Diabetes Mellitus/terapia , Telemedicina/métodos , Humanos
3.
Horm Res ; 66(1): 45-50, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16710096

RESUMEN

BACKGROUND: Iodine deficiency produces the spectrum of iodine deficiency disorders (IDDs): endemic goiter, hypothyroidism, cretinism, and congenital anomalies. Other factors, including goitrogens and micronutrient deficiencies, may influence the prevalence and severity of IDDs and response to iodine supplementation. This cross-sectional, descriptive study was performed in 2003 on elementary school children of Semirom, a mountainous region of Iran, where goiter was hyper-endemic in 1994, but the goiter prevalence had not decreased as expected many years after salt iodization and iodine injection. Some possible risk factors associated with goiter in that area were evaluated, and the results of iron study are presented here. METHODS: 1,869 cases were selected by a multistage cluster sampling procedure. Grade 2 goitrous children were compared with equal number of nongoitrous children for serum iron, ferritin, transferrin, thyroxin, TSH and urine iodine concentrations (UIC). RESULTS: 210 children (105 goiter grade 0 and 105 goiter grade 2) entered this sub-study. Of 210 participants, 70 children had low transferrin saturation, 13 had low serum ferritin and 9 children had both problems. There was no significant difference in goiter rate between children with low iron indices and others. There was no significant correlation between serum iron, ferritin or transferrin saturation with other variables including T4, UIC and goiter stage. CONCLUSION: The present study reveals that in the area studied, iron deficiency cannot explain the high prevalence of goiter, so other responsible factors should be investigated.


Asunto(s)
Bocio/complicaciones , Deficiencias de Hierro , Niño , Femenino , Ferritinas/sangre , Bocio/epidemiología , Humanos , Yodo/orina , Irán/epidemiología , Hierro/sangre , Masculino , Tirotropina/sangre , Tiroxina/sangre , Transferrina/análisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA